 | Up a level |
Pfeuffer, Steffen, Schmidt, Rene, Straeten, Frederike Anne, Pul, Refik, Kleinschnitz, Christoph 
ORCID: 0000-0002-1650-8875, Wieshuber, Marinus, Lee, De-Hyung, Linker, Ralf A., Doerck, Sebastian, Straeten, Vera, Windhagen, Susanne, Pawlitzki, Marc, Aufenberg, Christoph, Lang, Michael, Eienbroeker, Christian, Tackenberg, Bjoern, Limmroth, Volker, Wildemann, Brigitte, Haas, Juergen ORCID: 0000-0002-2314-7465, Klotz, Luisa, Wiendl, Heinz, Ruck, Tobias and Meuth, Sven G.
(2019).
Efficacy and safety of alemtuzumab versus fingolimod in RRMS after natalizumab cessation.
J. Neurol., 266 (1).
S. 165 - 174.
HEIDELBERG:
SPRINGER HEIDELBERG.
ISSN 1432-1459
Rolfes, Leoni, Pawlitzki, Marc, Pfeuffer, Steffen, Nelke, Christopher, Lux, Anke, Pul, Refik, Kleinschnitz, Christoph ORCID: 0000-0002-1650-8875, Kleinschnitz, Konstanze, Rogall, Rebeca, Pape, Katrin, Bittner, Stefan, Zipp, Frauke ORCID: 0000-0002-1231-1928, Warnke, Clemens, Goereci, Yasemin, Schroeter, Michael, Ingwersen, Jens, Aktas, Orhan, Klotz, Luisa, Ruck, Tobias ORCID: 0000-0001-6332-8650, Wiendl, Heinz and Meuth, Sven G.
(2021).
Ocrelizumab Extended Interval Dosing in Multiple Sclerosis in Times of COVID-19.
Neurol.-Neuroimmunol. Neuroinflammation, 8 (5).
PHILADELPHIA:
LIPPINCOTT WILLIAMS & WILKINS.
ISSN 2332-7812